Answers are grounded in this paper and cite their sources.
The Alzheimer's Disease Neuroimaging Initiative has successfully recruited cohorts of cognitively normal subjects, subjects with mild cognitive impairment (MCI), and subjects with Alzheimer disease with anticipated baseline characteristics. The 12-month progression rate of MCI was as predicted, and the CSF measures heralded progression of clinical measures over 12 months.
No takes yet. Share an insight, caveat, or question.
Petersen et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: